Wilhelmine H. Meeraus

Epidemiology, Value Evidence And Outcomes, Stockley Park
Uxbridge, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.

Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.

Journal: Infectious diseases and therapy

Published: January 15, 2026

Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study.

Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study.

Journal: Journal of epidemiology and global health

Published: November 09, 2025

Real-world Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children and Adolescents from 2003 to 2023: a Plain Language Summary of Publication.

Real-world Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children and Adolescents from 2003 to 2023: a Plain Language Summary of Publication.

Journal: Therapeutic advances in infectious disease

Published: September 17, 2025

Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness Studies.

Precautionary Health Behaviours as Potential Confounders in COVID-19 Vaccine Effectiveness Studies.

Journal: Vaccines

Published: August 28, 2025

Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis.

Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis.

Journal: Expert review of vaccines

Published: July 23, 2025

Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case-control study.

Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case-control study.

Journal: European journal of public health

Published: January 21, 2025

Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.

Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.

Journal: Drug safety

Published: December 10, 2024

Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron.

Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron.

Journal: Vaccine

Published: October 21, 2024

Correcting for the Inflated Adult Population Denominator in an English Nationwide Health Care Cohort: Database Analysis Study.

Correcting for the Inflated Adult Population Denominator in an English Nationwide Health Care Cohort: Database Analysis Study.

Journal: JMIR public health and surveillance

Published: July 26, 2024

Clinical characteristics, SARS-CoV-2 variants, and outcomes of adults hospitalized due to COVID-19 in Latin American countries.

Clinical characteristics, SARS-CoV-2 variants, and outcomes of adults hospitalized due to COVID-19 in Latin American countries.

Journal: Clinics (Sao Paulo, Brazil)

Published: July 22, 2024

Features influencing the health and economic impact of preventing COVID-19 in immunocompromised individuals.

Features influencing the health and economic impact of preventing COVID-19 in immunocompromised individuals.

Journal: PLoS computational biology

Published: May 03, 2024

Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN study.

Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN study.

Journal: PloS one

Published: March 22, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026